Bipolar charged aerosol agglomeration and collection by a two-zone agglomerator

ＩｎｔｒｏｄｕｃｔｉｏｎＢｅｃａｕｓｅｏｆｔｈｅｌｏｗｅｆｆｉｃｉｅｎｃｙｏｆｔｈｅｅｌｅｃｔｒｏｓｔａｔｉｃｐｒｅｃｉｐｉｔａｔｏｒ (ＥＳＰ)ｆｏｒｃｏｌｌｅｃｔｉｎｇｔｈｅｓｕｂｍｉｃｒｏｎｐａｒｔｉｃｌｅｓ ,ｔｈｅｅｌｅｃｔｒｉｃａｌａｇｇｌｏｍｅｒａｔｉｏｎｍｅｔｈｏｄｈａｓｌｅｄｔｏａｎｉｎｃｒｅａｓｉｎｇｉｎｔｅｒｅｓｔｉｎｒｅｄｕｃｉｎｇｔｈｅｅｍｉｓｓｉｏｎｏｆｔｈｅｆｉｎｅｐａｒｔｉｃｌｅｓ .Ｍａｎｙａｕｔｈｏｒｓｈａｖｅｓｔｕｄｉｅｄｅｌｅｃｔｒｉｃａｌａｇｇｌｏｍｅｒａｔｉ…     

Uncommon chromosomal mosaicism in chorionic villi

Three cases of unusual chromosomal mosaicism are reported for which the cytogenetic data show inconsistent findings between CVS and AC or fetal tissue, and which cannot be explained simply by non-disjunction. For case 1, in CVS the karyotype was 46,XY, whereas lymphocytes and fibroblasts revealed 69,XXY. DNA fingerprinting indicated one paternal and two maternal chromosome sets, the latter most probably due to omission of maternal meiosis II. For case 2, in CVS mos 46,XX/47,XX,+mar de novo was observed. Amniotic fluid cells had the karyotype 46,XX. The origin of the marker chromosome might be explained by at least two events of unknown order (a somatic chromosome/chromatid deletion and non-disjunction of the homologous chromosome). In case 3 (CVS: mos 46,XY/46,XY,19q+ de novo; amniotic fluid cells, lymphocytes, and fibroblasts: 46,XY), the surplus of chromosome material in 19q+ might be explained on the basis of a somatic translocation. The idea of a chimera is less convincing, as the mosaic finding is restricted to one tissue. Furthermore, there was no hint of a vanishing twin. Hitherto, no case of structural chromosome mosaicism in CVS has been reconfirmed in fetal tissues.     

Easurements of placental,decidual, and fetal proteins before and after chorionic villus sampling

Circulating placental [human chorionic gonadotrophin (hCG), Schwangerschafts protein 1 (SP1), pregnancy-associated plasma protein A (PAPP-A), decidual (pregnancy protein) 12 (PP12), and fetal alphafetoprotein (AFP)] proteins were measured immediately before and within 1 h in 18 women undergoing diagnostic chorionic villus sampling (CVS) in the first trimester. An elevation of serum AFP levels was consistently seen, while fluctuations in excess of 10 per cent of the pre-CVS levels of SP1 and PP12 were seen in the majority of patients. Fluctuations in hCG and PAPP-A were consistently less than 10 per cent of pre-CVS values. Post-CVS changes in levels were not apparently associated with any feature of the technique, the pregnancy, or its outcome (one missed abortion). As feto-maternal haemorrhage is a common event, anti-D should be offered to rhesus-negative women undergoing CVS. In the prediction of subsequent miscarriage, only hCG and PAPP-A measurements should be considered.